THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Chad Hamilton to Cell Line, Tumor

This is a "connection" page, showing publications Chad Hamilton has written about Cell Line, Tumor.
Connection Strength

0.234
  1. Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers. Cancer Med. 2020 02; 9(3):1092-1103.
    View in: PubMed
    Score: 0.032
  2. Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line. Hum Cell. 2017 Jul; 30(3):226-236.
    View in: PubMed
    Score: 0.027
  3. Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1. Oncotarget. 2016 Nov 22; 7(47):77576-77590.
    View in: PubMed
    Score: 0.026
  4. Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-? signaling pathway. Oncotarget. 2016 Oct 25; 7(43):69733-69748.
    View in: PubMed
    Score: 0.026
  5. Progestins inhibit calcitriol-induced CYP24A1 and synergistically inhibit ovarian cancer cell viability: An opportunity for chemoprevention. Gynecol Oncol. 2016 10; 143(1):159-167.
    View in: PubMed
    Score: 0.025
  6. Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells. Gynecol Oncol. 2015 Mar; 136(3):554-61.
    View in: PubMed
    Score: 0.023
  7. Progesterone inhibits endometrial cancer invasiveness by inhibiting the TGF? pathway. Cancer Prev Res (Phila). 2014 Oct; 7(10):1045-55.
    View in: PubMed
    Score: 0.022
  8. Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes. Br J Cancer. 2014 Jan 07; 110(1):123-32.
    View in: PubMed
    Score: 0.021
  9. Mitochondrial proteomic analysis of cisplatin resistance in ovarian cancer. J Proteome Res. 2012 Sep 07; 11(9):4605-14.
    View in: PubMed
    Score: 0.019
  10. Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study. Clin Cancer Res. 2006 Mar 15; 12(6):1859-67.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES